Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study
Maria Pia Amato(University of Florence), María Trojano(University of Bari Aldo Moro), Massimo Filippi(Vita-Salute San Raffaele University), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Girolama Alessandra Marfia(Erasmus University Rotterdam), Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Eleonora Baldi(Ospedale Sant'Anna), Nunzio Olivieri(Sanofi (Italy)), Alberto Farina(Sanofi (Italy)), Massimiliano Mirabella(Università Cattolica del Sacro Cuore), Umberto Aguglia(Martin University), Franco Parodi(Sanofi (Italy)), Sergio Sommacal(Sanofi (Italy)), Simona Malucchi(Ospedale San Luigi Gonzaga), Emilio Portaccio(University of Florence), Nicoletta Grassivaro(Sanofi (Italy)), Rocco Totaro(San Salvatore Hospital), Marco Rovaris(San Raffaele University of Rome), Paola Cavalla, Maurizio Assetta, Stefania Leoni(Azienda Ospedaliero Universitaria di Sassari), Giacomo Lus(University of Campania "Luigi Vanvitelli"), Cristoforo Comi(Vita-Salute San Raffaele University), Margaret Mondino(Sanofi (Italy)), Vincenzo Brescia Morra(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Luigi Maria Edoardo Grimaldi(Fondazione Istituto G. Giglio di Cefalù), Paola Perini(Azienda Ospedale - Università Padova), Mario Falcini(Hospital of Prato), Marcello Romano(Centre National de la Recherche Scientifique), Daniele Santo Todaro(Sanofi (Italy)), Diego Centonze(University of Rome Tor Vergata)
Cited by 2
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k